{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:50:44Z","timestamp":1784908244497,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFC2701601"],"award-info":[{"award-number":["2021YFC2701601"]}]},{"name":"fundings for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2024-LCYJ-DBZ-06"],"award-info":[{"award-number":["2024-LCYJ-DBZ-06"]}]},{"name":"fundings for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2022-YXZX-FC-02"],"award-info":[{"award-number":["2022-YXZX-FC-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08435-w","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:04:55Z","timestamp":1763463895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improved maternal outcome in placenta accreta spectrum disorders: a single-institute observational cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"16","key":"8435_CR1","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","volume":"378","author":"RM Silver","year":"2018","unstructured":"Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529\u201336.","journal-title":"N Engl J Med"},{"issue":"5","key":"8435_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ajog.2010.09.013","volume":"203","author":"P Committee","year":"2010","unstructured":"Committee P, S.f.M.-F.M. and, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8435_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ogc.2015.01.014","volume":"42","author":"RM Silver","year":"2015","unstructured":"Silver RM, Barbour KD. Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2015;42(2):381\u2013402.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"5","key":"8435_CR4","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","volume":"192","author":"S Wu","year":"2005","unstructured":"Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192(5):1458\u201361.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8435_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0002-9378(97)70463-0","volume":"177","author":"DA Miller","year":"1997","unstructured":"Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177(1):210\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"8435_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.placenta.2022.06.009","volume":"126","author":"Y Ming","year":"2022","unstructured":"Ming Y, et al. Epidemiology of placenta accreta spectrum disorders in Chinese pregnant women: a multicenter hospital-based study. Placenta. 2022;126:133\u20139.","journal-title":"Placenta"},{"issue":"6","key":"8435_CR7","first-page":"511","volume":"21","author":"KK Cheng","year":"2015","unstructured":"Cheng KK, Lee MM. Rising incidence of morbidly adherent placenta and its association with previous caesarean section: a 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J. 2015;21(6):511\u20137.","journal-title":"Hong Kong Med J"},{"issue":"9","key":"8435_CR8","first-page":"799","volume":"31","author":"ZS Bowman","year":"2014","unstructured":"Bowman ZS, et al. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31(9):799\u2013804.","journal-title":"Am J Perinatol"},{"issue":"3","key":"8435_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ijgo.12407","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux E, et al. Figo consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018;140(3):265\u201373.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"8435_CR10","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2018.09.042","volume":"219","author":"Society of Gynecologic","year":"2018","unstructured":"Society of Gynecologic. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2-16.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"8435_CR11","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1097\/AOG.0000000000002983","volume":"132","author":"O Gynecologists","year":"2018","unstructured":"American College of, Gynecologists O. Society for Maternal-Fetal, obstetric care consensus 7: placenta accreta spectrum. Obstet Gynecol. 2018;132(6):e259\u201375.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"8435_CR12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jogc.2018.12.004","volume":"41","author":"SR Hobson","year":"2019","unstructured":"Hobson SR. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders. J Obstet Gynaecol Can. 2019;41(7):1035\u201349.","journal-title":"J Obstet Gynaecol Can"},{"issue":"6","key":"8435_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ajog.2019.02.054","volume":"220","author":"SL Collins","year":"2019","unstructured":"Collins SL, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220(6):511\u201326.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8435_CR14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/1471-0528.15349","volume":"126","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, et al. Placenta praevia and placenta accreta: diagnosis and management: Green-top guideline No. 27a. BJOG. 2019;126(1):e1-48.","journal-title":"BJOG"},{"issue":"3","key":"8435_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ijgo.12408","volume":"140","author":"E Jauniaux","year":"2018","unstructured":"Jauniaux E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274\u201380.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"8435_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","volume":"212","author":"RM Silver","year":"2015","unstructured":"Silver RM, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212(5):561\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8435_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ijgo.15339","volume":"165","author":"K Muadtongon","year":"2024","unstructured":"Muadtongon K, et al. Successful multidisciplinary team management of placenta accreta spectrum disorder: a referral center model in a middle-income country. Int J Gynaecol Obstet. 2024;165(2):813\u201322.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"8435_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1515\/jpm-2021-0263","volume":"50","author":"K Sylvester-Armstrong","year":"2022","unstructured":"Sylvester-Armstrong K, et al. Improved management of placenta accreta spectrum disorders: experience from a single institution. J Perinat Med. 2022;50(3):286\u201393.","journal-title":"J Perinat Med"},{"issue":"2","key":"8435_CR19","doi-asserted-by":"publisher","first-page":"pe2181","DOI":"10.1016\/j.ajog.2014.08.019","volume":"212","author":"AA Shamshirsaz","year":"2015","unstructured":"Shamshirsaz AA, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(2):pe2181\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"8435_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1471-0528.2008.02037.x","volume":"116","author":"AG Eller","year":"2009","unstructured":"Eller AG, et al. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648\u201354.","journal-title":"BJOG"},{"issue":"1","key":"8435_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/AOG.0b013e3181c4f12a","volume":"115","author":"CR Warshak","year":"2010","unstructured":"Warshak CR, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115(1):65\u20139.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"8435_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2023.100188","volume":"3","author":"AJ Nieto-Calvache","year":"2023","unstructured":"Nieto-Calvache AJ, et al. Placenta accreta spectrum: treatment consensus in a resource-limited setting. AJOG Glob Rep. 2023;3(3):100188.","journal-title":"AJOG Glob Rep"},{"issue":"5","key":"8435_CR23","first-page":"486","volume":"34","author":"Y Yang","year":"2021","unstructured":"Yang Y, Xu YYX, Zhou Y, Ru T, Dai Y. Value analysis of sonographic grading diagnosis for placenta accreta spectrum. J Med Postgra. 2021;34(5):486\u20139.","journal-title":"J Med Postgra"},{"issue":"10","key":"8435_CR24","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1111\/jog.14982","volume":"47","author":"Q Li","year":"2021","unstructured":"Li Q, et al. Development and validation of a magnetic resonance imaging-based nomogram for predicting invasive forms of placental accreta spectrum disorders. J Obstet Gynaecol Res. 2021;47(10):3488\u201397.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"8435_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijoa.2013.11.002","volume":"23","author":"J Teare","year":"2014","unstructured":"Teare J, et al. Sciatic nerve ischaemia after Iliac artery occlusion balloon catheter placement for placenta percreta. Int J Obstet Anesth. 2014;23(2):178\u201381.","journal-title":"Int J Obstet Anesth"},{"issue":"3 Pt 2","key":"8435_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/01.AOG.0000201992.80130.2c","volume":"108","author":"MF Sewell","year":"2006","unstructured":"Sewell MF, Rosenblum D, Ehrenberg H. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol. 2006;108(3 Pt 2):746\u20138.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"8435_CR27","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1471-0528.2009.02217.x","volume":"116","author":"S Chouliaras","year":"2009","unstructured":"Chouliaras S, Hickling DJ, Tuck JS. Thromboembolism of the leg following prophylactic balloon occlusion of the uterine arteries. BJOG. 2009;116(9):1278\u20139.","journal-title":"BJOG"},{"issue":"11","key":"8435_CR28","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1111\/jog.12777","volume":"41","author":"S Matsueda","year":"2015","unstructured":"Matsueda S, et al. External iliac artery thrombosis after common iliac artery balloon occlusion during cesarean hysterectomy for placenta accreta in cervico-isthmic pregnancy. J Obstet Gynaecol Res. 2015;41(11):1826\u201330.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"8435_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-3148.2007.00744.x","volume":"17","author":"TTFFE Boulton","year":"2007","unstructured":"British Committee for Standards in Haematology, Boulton TTFFE, James V. Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion. Transfus Med. 2007;17(5):354\u201365.","journal-title":"Transfus Med"},{"issue":"2","key":"8435_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/FM9.0000000000000211","volume":"6","author":"J Ma","year":"2024","unstructured":"Ma J, Yang H. The evolution of management strategies for placenta accreta spectrum. Maternal-Fetal Medicine. 2024;6(2):106\u20139.","journal-title":"Maternal-Fetal Medicine"},{"issue":"12","key":"8435_CR31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","volume":"25","author":"G Ogrinc","year":"2016","unstructured":"Ogrinc G, et al. SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986\u201392.","journal-title":"BMJ Qual Saf"},{"issue":"7624","key":"8435_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"issue":"2 Pt 1","key":"8435_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/AOG.0b013e3182051db2","volume":"117","author":"AG Eller","year":"2011","unstructured":"Eller AG, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117(2 Pt 1):331\u20137.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"8435_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129170","volume":"10","author":"M Wang","year":"2015","unstructured":"Wang M, et al. Retrospective evaluation of new Chinese diagnostic scoring system for disseminated intravascular coagulation. PLoS ONE. 2015;10(6):e0129170.","journal-title":"PLoS ONE"},{"issue":"1","key":"8435_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/tme.12443","volume":"28","author":"M Munoz","year":"2018","unstructured":"Munoz M, et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 2018;28(1):22\u201339.","journal-title":"Transfus Med"},{"issue":"1","key":"8435_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ijgo.12761","volume":"146","author":"E Jauniaux","year":"2019","unstructured":"Jauniaux E, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"8435_CR37","doi-asserted-by":"publisher","first-page":"e6121","DOI":"10.1016\/j.ajog.2017.02.016","volume":"216","author":"AA Shamshirsaz","year":"2017","unstructured":"Shamshirsaz AA, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216(6):e6121\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"8435_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.transci.2018.11.003","volume":"57","author":"D Catic","year":"2018","unstructured":"Catic D, Milojkovic A, Steblovnik L. Preoperative autologous blood donation in placenta previa patients. Transfus Apher Sci. 2018;57(6):793\u20136.","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"8435_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijoa.2013.05.007","volume":"22","author":"A Elagamy","year":"2013","unstructured":"Elagamy A, Abdelaziz A, Ellaithy M. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. Int J Obstet Anesth. 2013;22(4):289\u201393.","journal-title":"Int J Obstet Anesth"},{"issue":"2S","key":"8435_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100745","volume":"5","author":"H Faysal","year":"2023","unstructured":"Faysal H, Araji T, Ahmadzia HK. Recognizing who is at risk for postpartum hemorrhage: targeting anemic women and scoring systems for clinical use. Am J Obstet Gynecol MFM. 2023;5(2S):100745.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"8","key":"8435_CR41","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1016\/S2214-109X(23)00245-0","volume":"11","author":"woman2@lshtm.ac.uk","year":"2023","unstructured":"woman2@lshtm.ac.uk. W.-t.c.E.a. And W.-t. collaborators, maternal anaemia And the risk of postpartum haemorrhage: a cohort analysis of data from the WOMAN-2 trial. Lancet Glob Health. 2023;11(8):e1249\u201359.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"8435_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ijgo.12740","volume":"144","author":"FW Medicine","year":"2019","unstructured":"Medicine FW. G.o.G.C.P.i.M.-F., good clinical practice advice: iron deficiency anemia in pregnancy. Int J Gynaecol Obstet. 2019;144(3):322\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"8435_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-06279-4","volume":"24","author":"B Zhang","year":"2024","unstructured":"Zhang B, et al. Obstetric blood transfusion in placenta previa patients with prenatal anemia: a retrospective study. BMC Pregnancy Childbirth. 2024;24(1):92.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"8435_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-02886-z","volume":"20","author":"H VanderMeulen","year":"2020","unstructured":"VanderMeulen H, et al. The contribution of iron deficiency to the risk of peripartum transfusion: a retrospective case control study. BMC Pregnancy Childbirth. 2020;20(1):196.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"11","key":"8435_CR45","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.2024.15196","volume":"332","author":"USPST Force","year":"2024","unstructured":"Force USPST, et al. Screening and supplementation for iron deficiency and iron deficiency anemia during pregnancy: US preventive services task force recommendation statement. JAMA. 2024;332(11):906\u201313.","journal-title":"JAMA"},{"issue":"10","key":"8435_CR46","first-page":"1060","volume":"27","author":"M Li","year":"2014","unstructured":"Li M, Wang YDZ, Gu N, Li J, Jiang H, Wen Q. Guijun Yan, feasibility and safety of preoperative autologous blood donation for pregnant patients. J Med Postgra. 2014;27(10):1060\u20134.","journal-title":"J Med Postgra"},{"issue":"3","key":"8435_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/0310057X1003800313","volume":"38","author":"NJ McDonnell","year":"2010","unstructured":"McDonnell NJ, et al. The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care. 2010;38(3):492\u20139.","journal-title":"Anaesth Intensive Care"},{"issue":"8","key":"8435_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.11622\/smedj.2015121","volume":"56","author":"E Lew","year":"2015","unstructured":"Lew E, Tagore S. Implementation of an obstetric cell salvage service in a tertiary women\u2019s hospital. Singap Med J. 2015;56(8):445\u20139.","journal-title":"Singap Med J"},{"issue":"2","key":"8435_CR49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijoa.2007.07.005","volume":"17","author":"CJ Nagy","year":"2008","unstructured":"Nagy CJ, Wheeler AS, Archer TL. Acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring in a Jehovah\u2019s witness with placenta percreta. Int J Obstet Anesth. 2008;17(2):159\u201363.","journal-title":"Int J Obstet Anesth"},{"issue":"5","key":"8435_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1213\/XAA.0000000000000258","volume":"6","author":"AA Mauritz","year":"2016","unstructured":"Mauritz AA, et al. Blood-conservation strategies in a blood-refusal parturient with placenta previa and placenta percreta. A & A Case Reports. 2016;6(5):111\u20133.","journal-title":"A & A Case Reports"},{"issue":"22","key":"8435_CR51","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010942","volume":"97","author":"K Zeng","year":"2018","unstructured":"Zeng K, et al. How about the effect of intraoperative cell salvage on allogeneic blood transfusion for patients with placenta accreta? An observational study. Medicine (Baltimore). 2018;97(22):e10942.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"8435_CR52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1067\/j.cpradiol.2017.10.010","volume":"47","author":"DA Petrov","year":"2018","unstructured":"Petrov DA, et al. Perioperative internal iliac artery balloon occlusion, in the setting of placenta accreta and its variants: the role of the interventional radiologist. Curr Probl Diagn Radiol. 2018;47(6):445\u201351.","journal-title":"Curr Probl Diagn Radiol"},{"key":"8435_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejogrb.2014.05.007","volume":"179","author":"G Cali","year":"2014","unstructured":"Cali G, et al. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 2014;179:36\u201341.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"8435_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2175-0","volume":"19","author":"L Chen","year":"2019","unstructured":"Chen L, et al. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2019;19(1):30.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"8435_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.08.001","volume":"197","author":"V Shrivastava","year":"2007","unstructured":"Shrivastava V, et al. Case-control comparison of Cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol. 2007;197(4):e4021\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8435_CR56","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1055\/s-0038-1641736","volume":"8","author":"E Blumenthal","year":"2018","unstructured":"Blumenthal E, et al. Pilot study of Intra-Aortic balloon occlusion to limit morbidity in patients with adherent placentation undergoing Cesarean hysterectomy. AJP Rep. 2018;8(2):e57\u201363.","journal-title":"AJP Rep"},{"issue":"2","key":"8435_CR57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijgo.2011.12.005","volume":"117","author":"E Chandraharan","year":"2012","unstructured":"Chandraharan E, et al. The triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet. 2012;117(2):191\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"8435_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100802","volume":"5","author":"AJ Nieto-Calvache","year":"2023","unstructured":"Nieto-Calvache AJ, et al. How to perform the one-step conservative surgery for placenta accreta spectrum move by move. American Journal of Obstetrics & Gynecology MFM. 2023;5(2):100802.","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"issue":"1","key":"8435_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ijgo.13717","volume":"157","author":"SR Hobson","year":"2022","unstructured":"Hobson SR, et al. Safer outcomes for placenta accreta spectrum disorders: a decade of quality improvement. Int J Gynaecol Obstet. 2022;157(1):130\u20139.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"8435_CR60","doi-asserted-by":"publisher","first-page":"101333","DOI":"10.1016\/j.ajogmf.2024.101333","volume":"6","author":"AJ Nieto-Calvache","year":"2024","unstructured":"Nieto-Calvache AJ, et al. One-step Conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial. Am J Obstet Gynecol MFM. 2024;6(6):101333.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10","key":"8435_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S1701-2163(16)35049-6","volume":"33","author":"H Amsalem","year":"2011","unstructured":"Amsalem H, et al. Planned caesarean hysterectomy versus conserving caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 2011;33(10):1005\u201310.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"8435_CR62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jpsychores.2007.03.018","volume":"63","author":"PC Leppert","year":"2007","unstructured":"Leppert PC, Legro RS, Kjerulff KH. Hysterectomy and loss of fertility: implications for women\u2019s mental health. J Psychosom Res. 2007;63(3):269\u201374.","journal-title":"J Psychosom Res"},{"issue":"12","key":"8435_CR63","doi-asserted-by":"publisher","first-page":"101189","DOI":"10.1016\/j.ajogmf.2023.101189","volume":"5","author":"H Zhao","year":"2023","unstructured":"Zhao H, et al. Subsequent pregnancy outcomes and risk factors following Conservative treatment for placenta accreta spectrum: a retrospective cohort study. Am J Obstet Gynecol MFM. 2023;5(12):101189.","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08435-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08435-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08435-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:04:44Z","timestamp":1763507084000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08435-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8435"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08435-w","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods of the study were carried out in accordance with Declaration of Helsinki and the protocol of the retrospective study was approved by the Ethic Review Committee of Nanjing Drum Tower Hospital (reference number 2023-239-01). Written informed consent was obtained from all women enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1231"}}